Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Skingenix, Inc. · NCT01297400
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 2
- Target enrollment
- 60
- US sites recruiting
- 4
- Study start
- March 11, 2022
- Record last updated
- March 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" (≥95% re-epithelialization) of a partial thickness target thermal burn.
Being studied: Investigational Drug, MW-III; Silvadene® Cream 1% [Silver Sulfadiazine]
Conditions: Burns
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults, 18 years of age or older on the day of signing the informed consent.
- Thermal Burns not exceeding a total body surface area (TBSA) OF 25%, with at least one partial thickness burn of 0.5% TBSA or greater. If full thickness burn(s) are present at screening, the total full thickness burn area shall not exceed 10% TBSA. Note: TBSA excludes areas of superficial (first degree) burns.
- Able and willing to give informed consent and comply with study procedures.
Exclusion Criteria
- Any burn that at screening is:
- infected.
- circumferential or deemed, in the judgment of the investigator, at high risk for developing compartment syndrome.
- partial thickness that is likely, in the judgment of the Investigator, to require grafting within 72 hours, or other non-protocol intervention.
- Severe inhalation injury or other significant non-burn trauma.
Recruiting US locations
Valleywise Health Medical Center
Phoenix, AZ 85008
University of CA Davis Medical Center
Sacramento, CA 95817
MedStar Washington Hospital Center
Washington D.C., DC 20010
University of Iowa Health Care
Iowa City, IA 52242
Study contacts (from the official record)
- Vicki Christodoulou, MS, JD · 909-587-1650 · vickic@skingenixusa.com
- Eric Wang, MD · 909-587-1650 · ericw@skingenixusa.com